Jing-Yuan Cao Selected Research

Jing-Yuan Cao Research Topics

Disease

7	Inflammation (Inflammations) 05/2023 - 01/2019
6	Fibrosis (Cirrhosis) 05/2023 - 01/2019
6	Hypoxia (Hypoxemia) 01/2023 - 12/2018
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
5	Neoplasms (Cancer) 01/2024 - 09/2019
3	Chronic Renal Insufficiency 01/2022 - 12/2018
3	Anemia 11/2020 - 12/2018
2	Genomic Instability 01/2024 - 01/2022
2	Ischemia 12/2022 - 10/2021
2	Kidney Diseases (Kidney Disease) 03/2022 - 07/2020
2	Ureteral Obstruction 10/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2019
2	Glioma (Gliomas) 01/2020 - 09/2019
1	Reperfusion Injury 05/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2022
1	Nephrolithiasis 01/2022
1	Dysbiosis 01/2022
1	Diabetes Complications 06/2021
1	Necrosis 01/2021
1	Carcinogenesis 09/2019
1	Secondary Hyperparathyroidism 07/2019
1	Hyperglycemia 01/2019
1	Iron Metabolism Disorders 12/2018
1	Hepatitis A (Hepatitis, Infectious) 12/2011

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2021
3	Prolyl-Hydroxylase InhibitorsIBA 01/2023 - 11/2019
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 12/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 12/2018
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2024
1	QuercetinIBA 05/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2023
1	Glycogen Synthase (Synthase I)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022
1	ElectrolytesIBA 10/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2022
1	roxadustatIBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 05/2022
1	CreatinineIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	AlbuminsIBA 03/2022
1	LigandsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Phosphorus (Red Phosphorus)IBA 01/2022
1	TensinsIBA 01/2022
1	Calcium OxalateIBA 01/2022
1	Peptides (Polypeptides)IBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 06/2021
1	Advanced Glycation End ProductsIBA 06/2021
1	Receptor for Advanced Glycation End ProductsIBA 06/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	HematinicsIBA 11/2020
1	InflammasomesIBA 07/2020
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 07/2020
1	A 68930IBA 07/2020
1	lymphocyte-specific protein p50IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	N- (bis(4- methoxyphenyl)methyl)- 4- hydroxy- 2- (pyridazin- 3- yl)pyrimidine- 5- carboxamideIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 09/2019
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 09/2019
1	Parathyroid Hormone (Parathormone)IBA 07/2019
1	Cinacalcet (Sensipar)FDA Link 07/2019
1	GlucocorticoidsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Erythropoietin FDA Link 12/2018
1	AntigensIBA 12/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019